SCHEMBL5801033

SCHEMBL5801033

N#CCNC(=O)C(Cc1cc(I)c(O)c(I)c1)NC(=O)c1ccc(N2CCN(C3CC3)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CTSK P43235 10/20 0.49
CTSL P07711 14/20 0.49
CTSS P25774 11/20 0.49
CTSB P07858 11/20 0.49
CTSV O60911 5/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6208313 0.88 CTSL (0.53) CTSKCTSLCTSSCTSBCTSV
SCHEMBL6208306 0.88 CTSL (0.53) CTSKCTSLCTSSCTSBCTSV
SCHEMBL5808560 0.87 ADRB3 (0.46)
SCHEMBL5800380 0.87 CTSL (0.52) CTSKCTSLCTSSCTSB
SCHEMBL5797321 0.85 POLB (0.45)
Lithium Ion SCHEMBL5808563 0.85 MEN1 (0.41) CTSK
SCHEMBL6268990 0.84 CTSK (0.49) CTSKCTSLCTSSCTSBCTSV
SCHEMBL6268987 0.84 CTSK (0.49) CTSKCTSLCTSSCTSBCTSV
SCHEMBL6272581 0.83 JAK2 (0.52) CTSKCTSLCTSSCTSBCTSV
SCHEMBL6272589 0.83 JAK2 (0.52) CTSKCTSLCTSSCTSBCTSV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006042103-A2 REVERSIBLE INHIBITORS OF CATHEPSIN B AXYS PHARMACEUTICALS, INC. (US) 2006-04-20 WO claimed
WO-2006042103-A2 REVERSIBLE INHIBITORS OF CATHEPSIN B AXYS PHARMACEUTICALS, INC. (US) 2006-04-20 WO disclosed